30 related articles for article (PubMed ID: 12480574)
1. Characterization of focal hepatic lesions with SPIO-enhanced MRI.
Zheng WW; Zhou KR; Chen ZW; Shen JZ; Chen CZ; Zhang SJ
World J Gastroenterol; 2002 Feb; 8(1):82-6. PubMed ID: 11833077
[TBL] [Abstract][Full Text] [Related]
2. Optimal scanning concentration of MR imaging for tumor-bearing nude mice with SPIO-shRNA molecular probe.
Zhang L; Yang X; Wen M
Sci Rep; 2020 Oct; 10(1):18655. PubMed ID: 33122685
[TBL] [Abstract][Full Text] [Related]
3. Ternary hybrid nanocomposites for gene delivery and magnetic resonance imaging of hepatocellular carcinoma cells.
Leung KC; Wong CH; Zhu XM; Lee SF; Sham KW; Lai JM; Chak CP; Wang YX; Cheng CH
Quant Imaging Med Surg; 2013 Dec; 3(6):302-7. PubMed ID: 24404444
[TBL] [Abstract][Full Text] [Related]
4. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
5. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
[TBL] [Abstract][Full Text] [Related]
6. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
Guo DM; Qiu TS; Bian J; Liu SF; Wang CZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
[TBL] [Abstract][Full Text] [Related]
8. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
[TBL] [Abstract][Full Text] [Related]
9. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
Liu X; Xu YK; Huang QL; Wu YK
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of hepatocellular carcinoma.
Onaya H; Itai Y
Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):757-68. PubMed ID: 11149678
[TBL] [Abstract][Full Text] [Related]
11. MR characterization of focal liver lesions: pearls and pitfalls.
Siegelman ES; Chauhan A
Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):295-313. PubMed ID: 25086931
[TBL] [Abstract][Full Text] [Related]
12. [MR imaging and dynamic MR imaging].
Yoshikawa K; Tobe K; Yoshioka N; Yoshida H
Nihon Rinsho; 1996 May; 54(5):1255-62. PubMed ID: 8965347
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]